Neuland Laboratories Limited (BSE: 524558)
Health Care · Pharmaceuticals · IN
Rs20,879.85
-2.87% today · +28.0% 1Y
Neuland Laboratories Limited (BSE: 524558) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.77B.
Over the last twelve months the share price has gained 28.0%, trading between 11.50K and 24.24K.
Tweenvest scores Neuland Laboratories Limited across four factors: quality 76/100, value 31/100, growth 82/100, dividend 65/100. Its strongest factor is growth.
524558 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.77B
- Revenue (TTM)
- $250.85M
- P/E
- 53.81
- EPS
- 388.01
- Dividend yield
- 0.16%
- Beta (5Y)
- 0.28
- 52-week high
- Rs24,235.05
- 52-week low
- Rs11,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.83M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunshine Lake Pharma Co., Ltd.SEHK: 6887 | $2.94B | HK$40.06 | -4.89% |
| Chengdu Kanghong Pharmaceutical Group Co., LtdSZSE: 002773 | $2.84B | CN¥20.66 | -5.23% |
| Kangmei Pharmaceutical Co., Ltd.SHSE: 600518 | $2.79B | CN¥1.35 | +0.75% |
| Harbin Pharmaceutical Group Co., Ltd.SHSE: 600664 | $2.78B | CN¥7.39 | -0.14% |
| Joincare Pharmaceutical Group Industry Co.,Ltd.SHSE: 600380 | $2.77B | CN¥10.13 | +2.32% |
| Piramal Pharma LimitedNSEI: PPLPHARMA | $2.70B | Rs196.88 | -0.55% |
| Acutaas Chemicals LimitedNSEI: ACUTAAS | $2.67B | Rs3,160.60 | -1.12% |
| Rubicon Research LimitedNSEI: RUBICON | $2.65B | Rs1,548.50 | -5.05% |
Figures last refreshed Oct 11, 2026.